PPARG and cancer: Furthermore, blocking SphK1, which activates S1P and catalyzes PPARγ synthesis, led to a certain anti‐tumor response in mouse models.[98] Therefore, the SphK1‐S1P pathway blockade may be a potential cancer treatment.